DualityBio and Genentech Partner on Next-Gen ADCs
SHANGHAI, CHINA, Aug 28, 2026 Duality Biotherapeutics, Inc. (DualityBio) has entered into a global collaboration and license agreement with...
Antibody-Drug Conjugates
Advertisement
Akeso Reports 2026 Growth, Advances Global Drug Pipeline
HONG KONG, Aug 27, 2026 Akeso, Inc. announced its 2026 interim results, reporting record commercial drug sales while advancing...
Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
Medtronic Expands Hugo Robotic Surgery System with New FDA Filings
GALWAY, Ireland, June 3, 2026 Medtronic has announced a series of major regulatory and clinical milestones aimed at significantly...
Lifordi Gains Major Investment to Advance ADC Autoimmune Therapy
Dateline Introduction Burlington, Massachusetts — November 18, 2025 — Lifordi Immunotherapeutics has announced a strategic investment from Sanofi Ventures,...
Advertisements
SystImmune Showcases Pivotal ADC Data at ESMO 2025, Strengthening Next-Generation Cancer Pipeline
REDMOND, Wash., Sept. 24, 2025 – SystImmune, Inc. announced the upcoming presentation of new clinical data on izalontamab brengitecan...
Daiichi Sankyo and Merck Strengthen ADC Pipeline with FDA Nod
BASKING RIDGE, N.J. and RAHWAY, N.J., September 15, 2025 – Daiichi Sankyo and Merck (known as MSD outside the...
Advertisement
